June 19, 2017 Avita Medical advises deploying a suspension of cells generated from a ReCell® medical device onto a skin donor site can speed up healing by 30.7% and deliver a superior final outcome, according to the results...
These data will be submitted to the U.S. Food and Drug Administration as part of an application to support Premarket Approval (PMA) for the ReCell® Autologous Cell Harvesting device.
LimFlow Receives FDA Approval for U.S. Feasibility Study of Minimally-Invasive Technology Designed to Restore Perfusion in “No Option” Critical Limb Ischemia Patients
When all other therapeutic options have been exhausted and a CLI patient is facing major amputation, the minimally-invasive LimFlow system is designed to bypass blocked arteries in the leg and rush oxygenated blood back into the foot.
April 13, 2017 Acelity, a global advanced wound care company, today announced that two significant enhancements to the V.A.C.ULTA™ Therapy System are now available in the U.S. The V.A.C.ULTA™ Therapy System, Acelity’s latest generation negative pressure wound therapy...
Clinical Trials and Studies
AMNIOX Highlights Three Studies Demonstrating Effectiveness of Umbilical Cord Tissue for Treating Chronic Wounds
April 7, 2017 AMNIOX Medical, Inc., a TissueTech, Inc. company, highlighted the publication of three studies concerning NEOX CORD 1K, its cryopreserved human umbilical cord tissue. In contrast to competitive offerings, these studies document the consistent effectiveness of the...
May 31, 2017 Acelity, a global advanced wound care company, today announced the global launch of the V.A.C. VERAFLO CLEANSE CHOICE Dressing, providing clinicians with a novel, adjunctive non-surgical option that may help clean large complex wounds when...